CA1163460A - Dosage immunologique d'antigenes - Google Patents

Dosage immunologique d'antigenes

Info

Publication number: CA1163460A
Authority: CA; Canada
Prior art keywords: antigen; oscillator; liquid sample; frequency; assay
Prior art date: 1980-05-06
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired

Application number

CA000351302A

Other languages

English (en)

Inventor

Robert J. Oliveira

Spencer F. Silver

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

3M Co

Original Assignee

Minnesota Mining and Manufacturing Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1980-05-06

Filing date

1980-05-06

Publication date

1984-03-13

1980-05-06 Application filed by Minnesota Mining and Manufacturing Co filed Critical Minnesota Mining and Manufacturing Co

1980-05-06 Priority to CA000351302A priority Critical patent/CA1163460A/fr

1984-03-13 Application granted granted Critical

1984-03-13 Publication of CA1163460A publication Critical patent/CA1163460A/fr

Status Expired legal-status Critical Current

Links

239000000427 antigen Substances 0.000 title claims abstract description 105
102000036639 antigens Human genes 0.000 title claims abstract description 105
108091007433 antigens Proteins 0.000 title claims abstract description 105
238000003018 immunoassay Methods 0.000 title description 4
239000000203 mixture Substances 0.000 claims abstract description 24
239000007788 liquid Substances 0.000 claims abstract description 15
230000008859 change Effects 0.000 claims abstract description 7
238000000034 method Methods 0.000 claims description 48
239000010453 quartz Substances 0.000 claims description 13
VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 13
239000013078 crystal Substances 0.000 claims description 12
239000002131 composite material Substances 0.000 claims description 10
108010074605 gamma-Globulins Proteins 0.000 claims description 10
210000002966 serum Anatomy 0.000 claims description 9
229910052751 metal Inorganic materials 0.000 claims description 7
239000002184 metal Substances 0.000 claims description 7
239000003814 drug Substances 0.000 claims description 6
230000000984 immunochemical effect Effects 0.000 claims description 6
239000013060 biological fluid Substances 0.000 claims description 5
229940079593 drug Drugs 0.000 claims description 5
239000004382 Amylase Substances 0.000 claims description 4
102000013142 Amylases Human genes 0.000 claims description 4
108010065511 Amylases Proteins 0.000 claims description 4
102000004506 Blood Proteins Human genes 0.000 claims description 4
108010017384 Blood Proteins Proteins 0.000 claims description 4
PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 claims description 4
108010071390 Serum Albumin Proteins 0.000 claims description 4
102000007562 Serum Albumin Human genes 0.000 claims description 4
235000019418 amylase Nutrition 0.000 claims description 4
239000003242 anti bacterial agent Substances 0.000 claims description 4
229940088710 antibiotic agent Drugs 0.000 claims description 4
238000006243 chemical reaction Methods 0.000 claims description 4
238000004519 manufacturing process Methods 0.000 claims description 4
210000002700 urine Anatomy 0.000 claims description 4
229940088594 vitamin Drugs 0.000 claims description 4
239000011782 vitamin Substances 0.000 claims description 4
229930003231 vitamin Natural products 0.000 claims description 4
235000013343 vitamin Nutrition 0.000 claims description 4
150000004676 glycans Chemical class 0.000 claims description 3
229940088597 hormone Drugs 0.000 claims description 3
239000005556 hormone Substances 0.000 claims description 3
102000039446 nucleic acids Human genes 0.000 claims description 3
108020004707 nucleic acids Proteins 0.000 claims description 3
150000007523 nucleic acids Chemical class 0.000 claims description 3
239000005017 polysaccharide Substances 0.000 claims description 3
229920001282 polysaccharide Polymers 0.000 claims description 3
229910052709 silver Inorganic materials 0.000 claims description 3
239000004332 silver Substances 0.000 claims description 3
-1 .alpha.-globulins Proteins 0.000 claims description 2
VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 claims description 2
239000001273 butane Substances 0.000 claims description 2
229910052804 chromium Inorganic materials 0.000 claims description 2
239000011651 chromium Substances 0.000 claims description 2
PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 2
229910052737 gold Inorganic materials 0.000 claims description 2
239000010931 gold Substances 0.000 claims description 2
229910052759 nickel Inorganic materials 0.000 claims description 2
229910052715 tantalum Inorganic materials 0.000 claims description 2
GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 claims description 2
BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims 1
238000003556 assay Methods 0.000 abstract description 43
102000004169 proteins and genes Human genes 0.000 abstract description 19
108090000623 proteins and genes Proteins 0.000 abstract description 19
239000000523 sample Substances 0.000 description 22
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 19
239000002953 phosphate buffered saline Substances 0.000 description 19
238000012875 competitive assay Methods 0.000 description 16
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 14
239000000243 solution Substances 0.000 description 14
238000002372 labelling Methods 0.000 description 12
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
239000000126 substance Substances 0.000 description 9
229920000642 polymer Polymers 0.000 description 8
238000002360 preparation method Methods 0.000 description 8
238000011534 incubation Methods 0.000 description 7
229910052757 nitrogen Inorganic materials 0.000 description 7
238000000926 separation method Methods 0.000 description 7
XUIIKFGFIJCVMT-GFCCVEGCSA-N D-thyroxine Chemical compound IC1=CC(C[C@@H](N)C(O)=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-GFCCVEGCSA-N 0.000 description 6
102000004190 Enzymes Human genes 0.000 description 6
108090000790 Enzymes Proteins 0.000 description 6
230000027455 binding Effects 0.000 description 6
238000000576 coating method Methods 0.000 description 6
229940034208 thyroxine Drugs 0.000 description 6
XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 description 6
XUIIKFGFIJCVMT-LBPRGKRZSA-N L-thyroxine Chemical compound IC1=CC(C[C@H]([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-LBPRGKRZSA-N 0.000 description 5
239000011248 coating agent Substances 0.000 description 5
239000008367 deionised water Substances 0.000 description 5
229910021641 deionized water Inorganic materials 0.000 description 5
238000001035 drying Methods 0.000 description 5
238000011067 equilibration Methods 0.000 description 5
229950008325 levothyroxine Drugs 0.000 description 5
241000894007 species Species 0.000 description 5
238000003756 stirring Methods 0.000 description 5
239000010410 layer Substances 0.000 description 4
239000000463 material Substances 0.000 description 4
230000035945 sensitivity Effects 0.000 description 4
150000003384 small molecules Chemical class 0.000 description 4
108010032597 Cohn fraction II Proteins 0.000 description 3
239000007864 aqueous solution Substances 0.000 description 3
239000012153 distilled water Substances 0.000 description 3
238000000763 radioactive isotope labeling Methods 0.000 description 3
239000007787 solid Substances 0.000 description 3
238000001179 sorption measurement Methods 0.000 description 3
QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
102000009027 Albumins Human genes 0.000 description 2
108010088751 Albumins Proteins 0.000 description 2
HXQQNYSFSLBXQJ-UHFFFAOYSA-N COC1=C(NC(CO)C(O)=O)CC(O)(CO)CC1=NCC(O)=O Chemical compound COC1=C(NC(CO)C(O)=O)CC(O)(CO)CC1=NCC(O)=O HXQQNYSFSLBXQJ-UHFFFAOYSA-N 0.000 description 2
SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 2
102000008100 Human Serum Albumin Human genes 0.000 description 2
108091006905 Human Serum Albumin Proteins 0.000 description 2
230000000890 antigenic effect Effects 0.000 description 2
239000007795 chemical reaction product Substances 0.000 description 2
239000003153 chemical reaction reagent Substances 0.000 description 2
239000003795 chemical substances by application Substances 0.000 description 2
DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
238000004132 cross linking Methods 0.000 description 2
238000000151 deposition Methods 0.000 description 2
239000006185 dispersion Substances 0.000 description 2
230000002255 enzymatic effect Effects 0.000 description 2
230000003100 immobilizing effect Effects 0.000 description 2
230000001900 immune effect Effects 0.000 description 2
238000002156 mixing Methods 0.000 description 2
238000006902 nitrogenation reaction Methods 0.000 description 2
238000002791 soaking Methods 0.000 description 2
239000007790 solid phase Substances 0.000 description 2
230000009870 specific binding Effects 0.000 description 2
239000002753 trypsin inhibitor Substances 0.000 description 2
238000005406 washing Methods 0.000 description 2
229910052727 yttrium Inorganic materials 0.000 description 2
101710088194 Dehydrogenase Proteins 0.000 description 1
102000008946 Fibrinogen Human genes 0.000 description 1
108010049003 Fibrinogen Proteins 0.000 description 1
102000014702 Haptoglobin Human genes 0.000 description 1
108050005077 Haptoglobin Proteins 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
102000036675 Myoglobin Human genes 0.000 description 1
108010062374 Myoglobin Proteins 0.000 description 1
239000004793 Polystyrene Substances 0.000 description 1
108010045362 Serum Globulins Proteins 0.000 description 1
102000005686 Serum Globulins Human genes 0.000 description 1
102000004142 Trypsin Human genes 0.000 description 1
108090000631 Trypsin Proteins 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
238000010420 art technique Methods 0.000 description 1
210000004369 blood Anatomy 0.000 description 1
239000008280 blood Substances 0.000 description 1
238000007385 chemical modification Methods 0.000 description 1
229920001688 coating polymer Polymers 0.000 description 1
230000002860 competitive effect Effects 0.000 description 1
230000000295 complement effect Effects 0.000 description 1
150000001875 compounds Chemical class 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
229940109239 creatinine Drugs 0.000 description 1
230000008021 deposition Effects 0.000 description 1
238000001514 detection method Methods 0.000 description 1
230000000694 effects Effects 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
229940012952 fibrinogen Drugs 0.000 description 1
229920002313 fluoropolymer Polymers 0.000 description 1
231100001261 hazardous Toxicity 0.000 description 1
230000002209 hydrophobic effect Effects 0.000 description 1
230000000951 immunodiffusion Effects 0.000 description 1
230000003993 interaction Effects 0.000 description 1
150000002605 large molecules Chemical class 0.000 description 1
239000007791 liquid phase Substances 0.000 description 1
229920002521 macromolecule Polymers 0.000 description 1
238000005259 measurement Methods 0.000 description 1
150000002739 metals Chemical class 0.000 description 1
210000000056 organ Anatomy 0.000 description 1
239000002245 particle Substances 0.000 description 1
239000004033 plastic Substances 0.000 description 1
229920002223 polystyrene Polymers 0.000 description 1
239000012460 protein solution Substances 0.000 description 1
BALXUFOVQVENIU-KXNXZCPBSA-N pseudoephedrine hydrochloride Chemical compound [H+].[Cl-].CN[C@@H](C)[C@@H](O)C1=CC=CC=C1 BALXUFOVQVENIU-KXNXZCPBSA-N 0.000 description 1
238000004451 qualitative analysis Methods 0.000 description 1
238000004445 quantitative analysis Methods 0.000 description 1
150000003254 radicals Chemical group 0.000 description 1
230000002285 radioactive effect Effects 0.000 description 1
238000003127 radioimmunoassay Methods 0.000 description 1
239000011541 reaction mixture Substances 0.000 description 1
230000004044 response Effects 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
239000002356 single layer Substances 0.000 description 1
159000000000 sodium salts Chemical class 0.000 description 1
239000006228 supernatant Substances 0.000 description 1
238000003786 synthesis reaction Methods 0.000 description 1
238000012360 testing method Methods 0.000 description 1
230000036962 time dependent Effects 0.000 description 1
238000011282 treatment Methods 0.000 description 1
239000012588 trypsin Substances 0.000 description 1
239000013026 undiluted sample Substances 0.000 description 1

Landscapes

Investigating Or Analysing Biological Materials (AREA)

CA000351302A 1980-05-06 1980-05-06 Dosage immunologique d'antigenes Expired CA1163460A (fr)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
CA000351302A CA1163460A (fr)	1980-05-06	1980-05-06	Dosage immunologique d'antigenes

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
CA000351302A CA1163460A (fr)	1980-05-06	1980-05-06	Dosage immunologique d'antigenes

Publications (1)

Publication Number	Publication Date
CA1163460A true CA1163460A (fr)	1984-03-13

Family

ID=4116868

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA000351302A Expired CA1163460A (fr)	1980-05-06	1980-05-06	Dosage immunologique d'antigenes

Country Status (1)

Country	Link
CA (1)	CA1163460A (fr)

1980
- 1980-05-06 CA CA000351302A patent/CA1163460A/fr not_active Expired

Legal Events

Date	Code	Title	Description
2001-03-13	MKEX	Expiry

Publication	Publication Date	Title
US4242096A (en)	1980-12-30	Immunoassay for antigens
US3949064A (en)	1976-04-06	Method of detecting antigens or antibodies
US4314821A (en)	1982-02-09	Sandwich immunoassay using piezoelectric oscillator
Suleiman et al.	1994	Recent developments in piezoelectric immunosensors. A review
FI92883C (fi)	1995-01-10	Testimenetelmä ja reagenssikitti sitä varten
CA1303981C (fr)	1992-06-23	Structures optiques recouvertes d'un polymere
EP0843816B1 (fr)	2000-12-27	Determination d'un analyte dans un milieu liquide
WO1985002258A1 (fr)	1985-05-23	Nouvelles analyses immunologiques et leurs kits d'utilisation
EP0026215A1 (fr)	1981-04-08	Procede de determination de classes d'anticorps d'antigenes specifiques.
JPH02156155A (ja)	1990-06-15	特異的結合性物質の測定法及び試薬
CA2093415C (fr)	2003-02-25	Methode et reactif pour l'analyse d'echantillons
Suri et al.	1995	Development of piezoelectric crystal based microgravimetric immunoassay for determination of insulin concentration
Le et al.	1995	A goat-anti-human IgG modified piezoimmunosensor for Staphylococcus aureus detection
US5468618A (en)	1995-11-21	Article for performing immunological assays utilizing organic dyes to immobilize immunologically reactive components to a solid phase support and methods for producing and utilizing same
Pei et al.	1998	A piezoelectric immunosensor for complement C4 using protein A oriented immobilization of antibody
CA1163460A (fr)	1984-03-13	Dosage immunologique d'antigenes
JPH0224559A (ja)	1990-01-26	免疫学的に検出可能な物質の測定法、反応容器及びイムノアツセイ原理による方法における種々のパラメーターの測定法
US4668637A (en)	1987-05-26	Method for detecting and dosing by erythroadsorption a biological substance
JPH01209370A (ja)	1989-08-23	免疫活性物質の測定法及び測定試薬
Ji‐Ming et al.	1998	Detection of complement C4 with a piezoelectric immunosensor
König et al.	1994	An immunosensor for the detection of human B-lymphocytes
CA1083036A (fr)	1980-08-05	Methode indirecte pour le dosage des antigenes ou des anticorps sur une surface solide
JP3727661B6 (ja)	2006-04-19	シグナル発生酵素としてバナジウムブロモペルオキシダーゼを使った特異的結合リガンドの測定用の分析要素および方法
JP3727661B2 (ja)	2005-12-14	シグナル発生酵素としてバナジウムブロモペルオキシダーゼを使った特異的結合リガンドの測定用分析要素および方法
Brown et al.	1979	Coated tube for immunochemical and enzymatic assays